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Factors contributing to COPD hospitalisations from 2010–2015: 
Variation among rural and metropolitan Australians. 
Introduction: Rural and remote populations experience the greatest burden of chronic 
obstructive pulmonary disease (COPD), the fifth leading cause of death in Australia. 
Currently there is a need to prioritise health services to improve health outcomes among 
those at higher risk of COPD.   
Objectives: To investigate the differences in COPD hospitalisation between rural and 
urban populations and determine predictive factors contributing to COPD hospitalisation.  
Methods: State-wide hospitalisation data from 2010 to 2015 were obtained through the 
Victorian Admitted Episodes Dataset and other key datasets. The rates of hospitalisation 
were analysed using hierarchical multiple regression to examine the association between 
COPD hospitalisations and a number of predictor variables.  
Results: The highest COPD incidence occurred in metropolitan males aged 85 years of 
age and older (35.092 hospitalisations per 1000 population). Among metropolitan 
residents, smoking, population density, and household income had a significant 
association with COPD hospitalisations for both sexes. Among rural males, smoking 
rates, household income, and rural land use (farming) were significant predictors of 
COPD hospitalisations. There was an overall stability in state-wide COPD hospitalisation 
over the five years to 2015, p=0.420.  
Conclusion: This investigation highlights many rural and regional areas have much 
lower COPD hospitalisation rates than metropolitan areas. Between males and females, 
there are heterogenetic factors that contribute to the significant variation associated with 
COPD hospitalisation in metropolitan and rural areas, such as rural land use among rural 
males. This indicates that risk factor assessments, beyond smoking alone, need to be 
individualised and prioritised in practice to optimise care. 
Keywords: Chronic Obstructive Pulmonary Disease, Hospitals, Chronic Disease, 
Self-Management, Urban Population, Rural Population 
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Introduction  
Chronic obstructive pulmonary disease (COPD) is an umbrella term that encompasses a 
group of progressive life-threatening lung diseases characterized by airway 
inflammation and airflow limitations1. COPD cannot be fully reversible and this chronic 
respiratory condition usually entails symptoms such as breathlessness, chronic cough, 
and sputum production with increasingly serious complications and exacerbations1. 
According to a recent report by WHO2, COPD claimed 3.17 lives per 100,000 
population in 2015, accounting for 5.7% of global total deaths and making it the fourth 
leading cause of deaths. In their projections about COPD in the next 15 years, Khakban 
and his colleagues3 predicted a substantial increase in the total number of COPD 
diagnoses (155%), COPD-related hospitalisations (210%) and the burden of inpatient 
care (182%) by 2030.  
In Australia, COPD is also a notable cause of mortality and disability that exerts 
a heavy burden on the health care system4. COPD affects about 17% of Australians 
aged 40 or over, and 29% of Australians in the 75-or-over age range5. As the fifth 
leading cause of death in Australia, COPD claimed the lives of 6,462 people in 2013 
(4.4% of the national total mortality) currently costing AUD$929 million/year and as 
much as AUD$8.8 billion in loss of productivity6.  
The well-documented risk factors of COPD include tobacco smoking; exposure 
to indoor, outdoor or occupational pollutants; socio-economic status (SES); age; and 
geographic location 5,7-10 For example, in Australia, COPD is reported in a higher 
proportion of the population in regional, rural and remote settings than in major cities7. 
People with COPD in rural areas encounter difficulties typical of lower socio-economic 
regions, such as extensive travel to access health care, poorer health services, unstable 
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local physician availability, exposure to health hazards, and a lack of respiratory-related 
education and support11. 
In the state of Victoria, Australia, hospitalisation rates for COPD have reflected 
the national trend with higher rates in rural than in metropolitan areas, and significant 
associations have been found between COPD hospitalisation rates and socio-economic 
status and remoteness of the area12. In their recent analysis of hospitalisation, 
readmissions, mortality, and burden of disease, Ore and Ireland 13 found significant 
inverse associations between COPD and SES, with Victorians in the most 
disadvantaged areas being most affected by COPD.  
Current evidence highlights the need to consider various contributing factors to 
COPD, and to prioritise health services and interventions to improve outcomes, 
especially for those with a higher risk of COPD.   
Aims 
To further understand COPD trends and associations in Australia, this paper aims to (1) 
investigate the differences in COPD hospitalisation across Victorian rural and urban 
areas and between age groups, (2) determine the key factors that have an impact on 
COPD among males and females in rural and urban regions; and (3) examine why key 
factors have a different impact on COPD hospitalisation between rural and urban 
counterparts.  
Materials and Methods 
Research site  
Victoria has a similar population size to Denmark with more than 6.1 million people 
living across the 237,269 square kilometre area14. It encompasses 79 local government 
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areas (LGA) that range from 20 to 22,213 square kilometres in size with population 
densities across the LGAs ranges from 0.47 to 4413.26 people per square kilometre. In 
the state, there are over 300 public and private hospitals including district hospitals and 
bush nursing services15. 
Data collection 
Hospitalisation data for a five-year period from 1 July 2010 to 30 June 2015 were 
obtained from the Victorian Admitted Episodes Dataset (VAED). As discussed 
elsewhere16, data included sex, age (5-year age groups), LGA or region of residence, 
private or public patient, bed days used as the unit of measurement for length of stay, 
type of discharge, and diagnosis on hospitalisation according the ICD-10-AM. COPD as 
the principal diagnosis was identified using the ICD-10-AM codes J43.1, J43.2, J43.8, 
J43.9, J44.0, J44.1, J44.8, and J44.9. Ethical approval for the research was obtained in 
March 2015. Others sources of data were included as outlined previously16, and were 
sourced from the Australian Bureau of Statistics17. 
Data analysis 
Population figures at the LGA level were used to calculate hospitalisation rates across 
the 79 LGAs in Victoria. Hospitalisations were divided by the corresponding population 
estimates for each year according to gender, age group and LGAs to obtain standardised 
hospitalisation rates. Age groups were examined only among adults (≥40 years ), given 
the relatively small number of COPD cases among individuals aged less than 40 years 
and the greater proportion of hospital expenditure occurring among the ≥40 years of age 
groups5. 
COPD and predictor variables were analysed according to hospitalisation rates 
using Statistical Package for the Social Sciences (SPSS, Version 22.0). Hierarchical 
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multiple regression was used to examine the association between COPD hospitalisations 
and a number of predictor variables. To adjust for percentage of smokers, this variable 
was entered at step 1 after which GPs per 1000 population, percentage of Aboriginal 
and Torres Strait Islanders, the four Socio-Economic Indexes for Areas which includes 
Index of Relative Socio-economic Advantage and Disadvantage (IRSAD), Index of 
Relative Socio-economic Disadvantage (IRSD), Index of Economic Resources (IER), 
Index of Education and Occupation (IEO), and also Accessibility and Remoteness Index 
of Australia 2011 (ARIA+) were entered into step 2. The initial analysis was conducted 
to ensure there was no violation of the assumptions of normality, homoscedasticity, 
multicollinearity, and liberality18. Significance was determined at two-tailed p < 0.05. 
Results 
Between the financial years 2010-11 and 2014-15, there were 71,262 total 
hospitalisations for COPD among Victorians aged 40 years old and older, of which 
46,074 (64.6%) occurred at metropolitan hospitals, 56,080 (78.6%) were 65 years of age 
or older, and 51,651 (72.4%) were publically funded hospitalisations. Females 
contributed towards 32,754 (46.0%) of all hospitalisations (Table 1). 
 
[Table 1 about here or as an online supplement] 
 
The incidence rate of COPD hospitalisations across the whole State over the 
five-year period was 5.264 (95% CI: 5.260-5.268) per 1000 population. The incidence 
rates were higher among the male population than the female population, while males 
aged 65 years and older had a higher incidence rate than females in the same age group. 
In addition to State averages, the mean hospitalisation rates were significantly higher 
among metropolitan males compared with rural males and were different among rural 
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and metropolitan females where rural females had higher rates than metropolitan 
females. However, when examining State-wide hospitalisation rates among the 85 years 
of age and over population, the mean rates were significantly higher among 
metropolitan males than rural males. Similarly, among females aged 85 years of age and 
over, metropolitan females had higher hospitalisation rates than rural females as 
demonstrated in Table 2 and Figure 1. 
 
[Table 2 about here] 
 
Figure 1: Hospitalisation incidence rate per 1000 population according to age, sex and 
residence 
 
[Figure 1 about here] 
 
 
Standardised hospitalisation rates for COPD between 2010-11 and 2014-15, and 
the overall mean Victorian incidence rates remained relatively stable with a non-
significant increase of 0.77% in the average hospital hospitalisations over the time 
period, p=0.420. The data highlights that despite differences between metropolitan and 
rural male and female hospitalisations, the change in rates between each group over the 
time period remained relatively similar. However, hospitalisation rates for COPD were 
consistently higher among metropolitan males compared to metropolitan females and 
both male and female rural Victorians over the five-year period, p=0.001.  
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Figure 2: Variation of hospitalisation incidence rates per 1000 population for COPD 
between 2010-11 and 2014-15 
[Figure 2 about here] 
 
Multiple regression analyses highlighted several significant predictors of COPD 
hospitalisation rates between metropolitan and rural sexes. After controlling for 
percentage of smokers, it was indicated that the predictor variables explained between 
60% and 78% of the variance that attributes to COPD hospitalisation (Table 3).  
 
[Table 3 about here] 
 
Among metropolitan residents, as outlined in Table 4, smoking, population 
density, and household income had a significant association with COPD disease 
hospitalisation rates for both females and males. Among metropolitan males the number 
of GPs per 1,000 population was also an additional significant predicting factor.  
When examining rural female residents, there were no significant associations 
with any of the factors identified. However, among rural males, percentage of smokers 
and household income were identified as significant predictors. Lastly, among rural 
males, rural land use such as farming, which is the most common use of rural land19, 
was also a predictor for COPD disease hospitalisation rates among rural males.  
 
[Table 4 about here] 
Discussion  
The overall findings are in line with the literature that has identified smoking as 
contributing to COPD23, and is reflective of it being one of the key factors leading to 
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hospitalisation among all cohorts except for rural females. Although smoking was 
indicated not to be significant among rural females, it was identified to be the factor that 
was likely to cause hospitalisation in this group. Apart from smoking having an 
association with COPD hospitalisations, there were divergent findings between 
metropolitan and rural males and female cohorts. For example, one of the key factors 
among metropolitan males was the proportion of GPs, where the greater the number of 
GPs in the areas, the more likely metropolitan males were to be hospitalised, which may 
reflect the increased diagnosis of COPD or the need of hospitalisations among males.  
This too may be reflective of why there is a higher hospitalisation rate among 
aboriginal men in metropolitan areas. These findings may be due to a lower percentage 
of aboriginal men and women in metropolitan Victoria24. This would suggest either 
there is greater proportion of metropolitan male aboriginals with a diagnosis of COPD, 
or this group of men seek care at the tertiary level, rather than at the primary care 
level25. Regardless, the rate remains alarming and highlights who shoulders the greater 
burden of disease and where health services need to prioritise key interventions to 
improve outcomes.  
Among metropolitan females, it was found that those who are more 
socioeconomically disadvantaged are more likely to be hospitalised with COPD, which 
suggests that they do not have appropriate access to or are less likely to engage with 
primary health care services, and may be more likely to have the low levels of health 
literacy concerning COPD management11. Further, among rural males, a key finding 
was as household income increased, their rate of COPD hospitalisation decreased. 
However, of greatest concern is the percentage of land use impacting COPD 
hospitalisation among rural males. It was highlighted that the greater the percentage of 
land being used for farming rural areas the greater the rate of COPD hospitalisations 
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occurred. One possible reason is living and working in rural areas has the potential for 
greater exposure to fumes, dust, pesticides and herbicides which may be a contributing 
factor to chronic respiratory illnesses such as COPD26. 
Regardless of these findings, the study demonstrated that there was an overall 
stability in state-wide hospitalisation for COPD over the five years from 2010 to 2015 
with the highest incidence occurring among metropolitan males, and contrary to 
previous research or projections12. Further, it was highlighted that hospitalisation rates 
among rural females aged 65 years and over were significantly higher than their 
metropolitan counterparts, and consistent with the globally observed increase in the 
prevalence of COPD in females20.  
Overall, metropolitan males aged 85 or more years of age had the highest 
hospitalisation rates than all age groups and cohorts, and males aged 75 years and older 
were consistently higher than other cohorts of the same age. However, rural females 
shared a similar incidence rates with metropolitan males until the age of 75 year or older 
when rural female hospitalisation rates steadily decreased until they paralleled rural 
males and metropolitan females over the age of 85 years. These findings are in line with 
the current body of research which indicates that COPD incidence increases with age5,8 
and peaks among those aged 75 or older21.  
Beyond the key factors identified as contributing to COPD hospitalisations, 
patients may experience delays in accessing medical care, particularly in rural area, or 
may tolerate worsening symptoms and only seek medical care when symptoms reach a 
critical point27. Further, it has been identified that knowledge of COPD is often 
inadequate among patients and they are less-equipped to manage acute episodes.  In one 
study, it was shown that only a third of people diagnosed with COPD received a written 
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action plan, compared with asthma patients who were given written action plans by GPs 
in 52.9% of cases28. 
The current best practice for diagnosing and care of individuals with COPD 
focuses on confirming diagnosis and severity of COPD, optimising function, preventing 
deterioration, developing support networks and self-management strategies29. However, 
clinical practice does not always reflect current recommendations and identifying 
COPD symptoms and risk factors may be under-appreciated in practice30. Nevertheless, 
this research has highlighted the relative stable hospitalisation rates over a five-year 
period, suggesting inroads are being achieved. However, the study also emphasised the 
groups that are most vulnerable, key factors contributing to COPD, while indicated 
where resources and health services need to be prioritised.   
A limitation of this study was that it was a retrospective study that examined 
COPD hospitalisation data. The dataset used in this study provided information on each 
admitted patient episode; however, waiting times, severity of illness, rates of patient 
readmission, or quality of treatment were not provided, and therefore, could not be 
determined or analysed. Nevertheless, the study incorporates a complete dataset of 
state-wide COPD hospitalisation between 2010 and 2015 and provides insight into the 
urban-rural differences across an Australian state where more than one-quarter of the 
Australian population resides. 
This investigation provides insight into the key factors that contribute to the 
significant variation associated with COPD hospitalisation in metropolitan and rural 
areas in Victoria. Those key factors are smoking, social disadvantage, cultural 
background, access to primary care, gender and age. It was found that COPD among 
older metropolitan males was much higher than other cohorts. It may indicate that these 
higher rates occur due to greater accessibility to primary health care or that greater 
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numbers of GPs in the LGA increases the likelihood for interventions at the tertiary 
level. These results add to the emerging literature concerning geographic and gender 
disparities among patients with COPD. Thus, public health efforts and health services 
interventions concerning COPD management should aim to improve the quantity and 
quality of primary health care delivery, while focusing on holistic strategies that address 
the needs of the individual, community, workplace and policies for in both rural and 
metropolitan areas. Although barriers to healthcare access are diverse and often 
complex, future research and healthcare must appreciate the unique factors that impact 
COPD outcomes among different groups of individuals. 
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Table 1: Descriptive data associated with COPD hospitalisations between rural and metropolitan males and females from 2010-11 to 2014-15 
Females  Males 
Patient factor Metropolitan Rural  Metropolitan Rural 
Age (years) Frequency Percentage Frequency Percentage  Frequency Percentage Frequency Percentage 
40–44 years 
45–49 years 
50–54 years 
55–59 years 
60–64 years 
65–69 years 
70–74 years 
75–79 years 
80–84 years 
85+ years 
259 
464 
706 
1217 
1977 
2820 
3163 
3266 
3657 
2864 
1.2 
2.2 
3.3 
5.7 
9.2 
13.2 
14.8 
15.3 
17.1 
18.1 
168 
267 
563 
806 
1116 
1453 
1983 
1880 
1649 
1476 
1.5 
2.4 
5.0 
7.1 
9.8 
12.8 
17.5 
16.5 
14.5 
13.0 
 170 
334 
524 
1278 
1922 
2993 
3788 
4420 
4653 
4599 
0.7 
1.4 
2.1 
5.2 
7.8 
12.1 
15.3 
17.9 
18.9 
18.7 
100 
182 
393 
583 
1153 
1786 
2306 
2488 
2552 
2284 
0.7 
1.3 
2.8 
4.2 
8.3 
12.9 
16.7 
18.0 
18.5 
16.6  
Where hospitalised          
Metropolitan 
Rural 
20762 
227 
98.9 
1.1 
631 
11134 
5.4 
94.6 
 24073 
252 
99.0 
1.0 
608 
13575 
4.3 
95.7 
Patient type          
Public 
Private 
Other 
14232 
6724 
33 
67.8 
32.0 
0.2 
9281 
2479 
5 
78.8 
21.1 
0.1 
 17354 
6892 
79 
71.3 
28.4 
0.3 
10784 
3366 
33 
76.0 
23.7 
0.2 
Hospitalisation type           
Elective 
Emergency 
Other 
17045 
3629 
315 
81.2 
17.3 
1.5 
9303 
2093 
369 
79.1 
17.8 
3.1 
 3575 
20410 
340 
83.9 
14.7 
1.4 
11385 
2448 
350 
80.3 
17.3 
2.5 
Hospital discharge mode         
To private accommodation 
To other care 
Left against medical advice 
Death 
15680 
3994 
137 
748 
76.3 
19.4 
0.9 
3.6 
9220 
1548 
89 
421 
81.8 
13.7 
0.8 
3.7 
 18725 
4030 
194 
920 
78.4 
16.8 
1.0 
3.8 
11191 
1809 
108 
574 
81.8 
13.2 
0.8 
4.2 
Length of stay 
Mean 
Range 
6.29  
1.00 – 181.00 
6.43  
1.00 – 325.00 
5.76 
1.00-231.00 
6.17 
1.00 – 260.00 
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Table 2: Incidence rate per 1000 population of COPD hospitalisations 
   
 Incidence 
rate 95% CI 
Incidence 
rate 95% CI p-vale 
 Rural Metropolitan  
Males 
- Aged over 65 years 
- Aged over 85 years 
Females 
- Aged over 65 years 
- Aged over 85 years 
3.728 
8.886 
14.034 
4.059 
12.717 
13.599 
3.723-3.734 
8.862-8.910 
13.918-14.149 
4.054-4.063 
12.676-12.758 
13.489-13.709 
6.261 
16.302 
35.092 
6.334 
9.998 
14.435 
6.251-6.270 
16.259-16.345 
34.810-35.374 
6.321-6.346 
9.977-10.019 
14.361-14.509 
.001 
.001 
.001 
.001 
.001 
.001 
* p < 0.05      
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Table 3: Hierarchical Multiple Regression model summary 
 Percentage of variance§ ANOVA† 
Metropolitan males 78.2% F(13,30)= 4.678, p = .002 
Rural Males 69.5% F(13,47)= 5.967, p = .001 
Metropolitan Females 75.6% F(13,30)= 4.048, p = .004 
Rural Females 60.4% F(13,47)= 3.982, p = .001 
§Indicates the proportion that the factors in the model are responsible for COPD. † F-statistic used to 
test the hypothesis that the data set in the regression analysis follows the simpler of two proposed 
linear models that are nested within each other. 
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Table 4: Regression analysis of COPD and rurality from 2010-11 to 2014-15 
 Females 
 Metropolitan  Rural 
Predictor Adj.OR± 95% CI p-value  Adj.OR 95% CI p-value 
Percentage of smokers  
GP attendance per 1,000 pop. 
Population density (Km2) 
IRSAD  
IRSD 
IER 
IEO 
ARIA+ score 
GPs per 1,000 population 
Household income 
Unemployment rate 
Percentage of ATSI population 
Land use, rural (%) 
1.071 
0.997 
1.000 
0.999 
1.000 
1.016 
0.987 
0.342 
3.426 
0.997 
0.983 
3.509 
0.886 
1.016-1.128 
0.915-1.086 
1.000-1.001 
0.998-0.999 
0.975-1.027 
0.999-1.034 
0.963-1.012 
0.069-1.679 
0.911-12.877 
0.996-0.999 
0.817-1.183 
0.768-16.035 
0.564-1.391 
0.01* 
0.01* 
0.02* 
0.80 
0.94 
0.05 
0.31 
0.17 
0.07 
0.03* 
0.85 
0.10 
0.45 
 
1.111 
0.984 
1.000 
0.999 
1.054 
1.028 
1.017 
0.741 
1.021 
0.995 
0.653 
0.974 
1.011 
0.982-1.257 
0.999-1.001 
0.990-1.008 
0.780-1.031 
0.966-1.150 
0.975-1.084 
0.970-1.065 
0.349-1.570 
0.253-4.112 
0.986-1.003 
0.368-1.158 
0.461-2.058 
0.793-1.291 
0.09* 
0.32 
0.91 
0.12 
0.22 
0.29 
0.46 
0.42 
0.97 
0.26 
0.14 
0.94 
0.92 
 Males 
 Metropolitan  Rural 
Predictor Adj.OR 95% CI p-value  Adj.OR 95% CI p-value 
 
Percentage of smokers  
GP attendance per 1,000 pop.  
Population density (Km2) 
IRSAD 
IRSD 
IER 
IEO 
ARIA+ score 
GPs per 1,000 population 
Household income 
Unemployment rate 
Percentage of ATSI population 
Land use, rural (%) 
1.054 
0.999 
1.000 
1.020 
0.982 
1.010 
0.988 
1.316 
3.753 
0.996 
0.903 
3.814 
0.926 
1.001-1.110 
0.999-1.000 
1.000-1.000 
0.969-1.074 
0.959-1.005 
0.995-1.26 
0.966-1.011 
0.314-5.516 
1.139-12.366 
0.995-0.998 
0.764-1.067 
0.970-14.984 
0.710-1.207 
0.04* 
0.59 
0.02* 
0.41 
0.12 
0.16 
0.29 
0.69 
0.03* 
0.01* 
0.22 
0.05 
0.42 
 
1.181 
1.000 
1.004 
0.946 
1.070 
1.038 
1.001 
1.949 
1.908 
0.987 
1.342 
0.842 
1.289 
1.029-1.356 
0.999-1.001 
0.995-1.013 
0.822-1.089 
0.980-1.168 
0.984-1.095 
0.955-1.049 
0.914-4.154 
0.469-7.764 
0.978-0.995 
0.754-2.390 
0.396-1.789 
1.008-1.649 
0.02* 
0.13 
0.29 
0.43 
0.13 
0.16 
0.96 
0.08 
0.36 
0.01* 
0.31 
0.65 
0.04* 
* p < 0.05; ±Adj.OR= Adjusted Odds Ratio (After controlling for smoking). 
 
 
